Kansas University Medical Center
Kansas University Medical Center
Kansas City, Kansas, United States25 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ivosidenib as Post-HSCT Maintenance for AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 2 | 2026-10-05 | NCT06707493 | |
| Early Feasibility Study - Edwards APTURE Transcatheter Shunt System | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-10-02 | NCT03523416 | |
| A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease | Fistulizing Crohns Disease; Perianal Crohns Disease | Active, not recruiting | Phase 3 | 2026-09-25 | NCT05347095 | |
| Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Not applicable | 2026-09-14 | NCT04905069 | |
| AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epileptic Syndromes, Hippocampal Sclerosis, Malformations of Cortical Development, Group I, brain disorder, central nervous system disorder, central nervous system malformation, cerebral cortical dysplasia, epilepsy, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-08-24 | NCT06063850 | |
| A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Phase 3 | 2026-07-29 | NCT05269004 | |
| Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-06-10 | NCT06526195 | |
| Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Muscular Disorders, Atrophic, hereditary disease, inherited neurodegenerative disorder, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic dystrophy type 1, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease | Recruiting | Not stated | 2026-06-10 | NCT03981575 | |
| Collaboration for Down Syndrome Progress (CDP) | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Neurobehavioral Manifestations, Neurologic Manifestations, chromosomal disorder, developmental disability, hereditary disease, intellectual disability, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Recruiting | Not stated | 2026-06-04 | NCT07625579 | |
| ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2026-06-04 | NCT05686317 | |
| MitraClip REPAIR MR Study | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Active, not recruiting | Not applicable | 2026-05-15 | NCT04198870 | |
| External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial | Brain Injuries, Traumatic, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, intracranial hypertension, nervous system disorder, nervous system injury | Recruiting | Not applicable | 2026-04-22 | NCT05889650 | |
| Prebiotic Galacto-oligosaccharide and Acute GVHD | Acute GVHD | Recruiting | Phase 1 / Phase 2 | 2026-04-22 | NCT04373057 | |
| Citadel Embolization Device Study | Unruptured Wide-neck Aneurysms | Active, not recruiting | Not applicable | 2026-03-30 | NCT04057352 | |
| Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-03-24 | NCT05478304 | |
| Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hereditary Complement Deficiency Diseases, Hypersensitivity, Immediate, Primary Immunodeficiency Diseases, Skin and Connective Tissue Diseases, angioedema, cardiovascular disorder, hereditary angioedema, hereditary disease, immune system disorder, inborn error of immunity, skin disorder, skin vascular disease, urticaria, vascular disorder | Recruiting | Phase 2 | 2026-02-27 | NCT06919003 | |
| A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy | Heart Transplant Failure and Rejection | Active, not recruiting | Not applicable | 2026-02-27 | NCT06414603 | |
| TRISCEND II Pivotal Trial | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, tricuspid valve disorder, tricuspid valve insufficiency | Active, not recruiting | Not applicable | 2026-02-27 | NCT04482062 | |
| Amplatzer Amulet LAAO vs. NOAC | Arrhythmias, Cardiac, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, nervous system disorder, stroke disorder, vascular disorder | Active, not recruiting | Not applicable | 2026-02-10 | NCT04226547 | |
| Abbott DBS Post-Market Study of Outcomes for Indications Over Time | Dyskinesias, Dystonia, Primary, Dystonia, Secondary, Neurologic Manifestations, Parkinson disease, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Tremor, basal ganglia disorder, brain disorder, central nervous system disorder, dystonic disorder, essential tremor, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Not stated | 2026-01-08 | NCT04071847 | |
| Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Not stated | 2025-11-03 | NCT06683092 | |
| Talk With Me Baby to Enhance the Early Home Language Environment | Infant Behavior; Infant Development; Language; Language Development; Language, Child; Speech | Recruiting | Not applicable | 2025-08-29 | NCT06479278 | |
| TRILUMINATE Pivotal Trial | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Active, not recruiting | Not applicable | 2024-12-19 | NCT03904147 | |
| Encore PFO Closure Device - The PerFOrm Trial | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cryptogenic Ischemic Stroke, atrial septal defect, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, congenital heart disease, heart disorder, heart septal defect, ischemic stroke, nervous system disorder, patent foramen ovale, stroke disorder, vascular disorder | Recruiting | Not applicable | 2024-09-19 | NCT05537753 | |
| SPI-1005 Treatment in Moderate COVID-19 Patients | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Enrolling by invitation | Phase 2 | 2023-10-03 | NCT04484025 |